Skip to main content
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · IEX Real-Time Price · USD
6.10
-0.08 (-1.29%)
May 17, 2024, 4:00 PM EDT - Market closed

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $200.79M in the twelve months ending March 31, 2024, with 20.91% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $44.86M with 20.96% year-over-year growth. In the year 2023, Cytek Biosciences had annual revenue of $193.02M with 17.67% growth.

Revenue (ttm)
$200.79M
Revenue Growth
+20.91%
P/S Ratio
3.98
Revenue / Employee
$297,021
Employees
676
Market Cap
799.45M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareDx 275.11M
Canopy Growth 248.53M
Arcturus Therapeutics Holdings 124.53M
REGENXBIO 86.73M
Tango Therapeutics 37.23M
Revenue Rankings

CTKB News

More News